The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD) Neurontin Tablets, 600 mg and 800 mg, of Viatris Specialty
Doxazosin tablets are indicated for the treatment of hypertension, to lower blood pressure
The current annual U.S. market for Sildenafil for Oral Suspension is approximately $43 million
Gabapentin Tablets are indicated for management of postherpetic neuralgia in adults
Extended Phenytoin Sodium Capsules are indicated for the treatment of tonic-clonic (grand mal) and psychomotor (temporal lobe) seizures
Sildenafil for Oral Suspension (RLD Revatio) had estimated annual sales of US $64 million in the US
The product will be manufactured at Lupin’s facility in Goa, India
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)